Palatin Technologies Inc
PTN0.094USD
-0.076-44.65%
交易中 （美东）报价延迟15分钟
2.21M总市值
亏损市盈率 TTM
关于 Palatin Technologies Inc 公司
Palatin Technologies, Inc. 是一家生物制药公司。该公司致力于开发基于调节黑皮质素受体系统活性的分子的药物。该公司的候选产品是针对性受体特异性治疗药物，用于治疗具有未满足医疗需求和商业潜力的疾病。其新产品开发活动主要集中在 MC1r 激动剂上，具有治疗炎症和自身免疫性疾病的潜力，例如干眼症（也称为干燥性角结膜炎）、葡萄膜炎、糖尿病视网膜病变和炎症性肠病。该公司还在开发对多种黑皮质素受体有活性的肽，以及 MC4r 肽和小分子激动剂，这些激动剂可能用于治疗肥胖和代谢相关疾病，包括罕见疾病和孤儿适应症。其候选产品包括用于治疗干眼症的 PL9643 和用于治疗溃疡性结肠炎的 PL8177。
公司简介
公司代码PTN
公司名称Palatin Technologies Inc
上市日期Dec 21, 1999
成立日期1986
CEODr. Carl Spana, Ph.D.
员工数量30
证券类型Ordinary Share
年结日Dec 21
公司地址4B Cedar Brook Drive
城市CRANBURY
上市交易所NYSE American Consolidated
国家United States of America
邮编08512
电话16094952200
网址https://www.palatin.com/
公司代码PTN
上市日期Dec 21, 1999
成立日期1986
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Carl Spana, Ph.D.
Dr. Carl Spana, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
261.46K
-23.20%
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
235.46K
-22.66%
Mr. Joseph Stanley Hull
Mr. Joseph Stanley Hull
Independent Director
Independent Director
30.27K
-28.39%
Dr. Anthony M. Manning, Ph.D.
Dr. Anthony M. Manning, Ph.D.
Independent Director
Independent Director
24.08K
-33.26%
Ms. Arlene M. Morris
Ms. Arlene M. Morris
Independent Director
Independent Director
--
--
Dr. John K. A. Prendergast
Dr. John K. A. Prendergast
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert K. Deveer, Jr.
Mr. Robert K. Deveer, Jr.
Independent Director
Independent Director
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Carl Spana, Ph.D.
Dr. Carl Spana, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
261.46K
-23.20%
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
235.46K
-22.66%
Mr. Joseph Stanley Hull
Mr. Joseph Stanley Hull
Independent Director
Independent Director
30.27K
-28.39%
Dr. Anthony M. Manning, Ph.D.
Dr. Anthony M. Manning, Ph.D.
Independent Director
Independent Director
24.08K
-33.26%
Ms. Arlene M. Morris
Ms. Arlene M. Morris
Independent Director
Independent Director
--
--
Dr. John K. A. Prendergast
Dr. John K. A. Prendergast
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Armistice Capital LLC
3.60%
Integral Health Asset Management, LLC
2.15%
The Vanguard Group, Inc.
1.27%
Spana (Carl)
0.56%
Geode Capital Management, L.L.C.
0.55%
Other
91.86%
持股股东
持股股东
占比
Armistice Capital LLC
3.60%
Integral Health Asset Management, LLC
2.15%
The Vanguard Group, Inc.
1.27%
Spana (Carl)
0.56%
Geode Capital Management, L.L.C.
0.55%
Other
91.86%
股东类型
持股股东
占比
Hedge Fund
5.82%
Investment Advisor/Hedge Fund
2.69%
Individual Investor
1.69%
Investment Advisor
0.90%
Research Firm
0.02%
Other
88.88%
机构持股
更新时间: 3月4日 周二
更新时间: 3月4日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q1
84
4.38M
16.86%
+1.71M
2024Q4
86
4.37M
16.81%
+1.70M
2024Q3
83
2.28M
10.81%
-1.78M
2024Q2
109
3.64M
20.41%
+1.60M
2024Q1
111
1.78M
11.91%
-743.00K
2023Q4
114
2.29M
17.05%
-582.75K
2023Q3
116
2.63M
22.43%
+838.36K
2023Q2
118
2.93M
25.24%
+1.19M
2023Q1
127
1.23M
11.29%
-1.28M
2022Q4
138
2.01M
19.55%
+390.54K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Armistice Capital LLC
1.99M
7.66%
+1.99M
--
Dec 31, 2024
The Vanguard Group, Inc.
591.85K
2.28%
-1.97K
-0.33%
Dec 31, 2024
Spana (Carl)
261.46K
1.01%
-79.00K
-23.20%
Sep 27, 2024
Geode Capital Management, L.L.C.
190.55K
0.73%
+8.85K
+4.87%
Dec 31, 2024
Wills (Stephen T)
235.46K
0.91%
-69.00K
-22.66%
Sep 27, 2024
Squarepoint Capital LLP
30.79K
0.12%
+30.79K
--
Dec 31, 2024
LPL Financial LLC
186.31K
0.72%
-84.00
-0.05%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
156.04K
0.6%
+248.00
+0.16%
Dec 31, 2024
deVeer (Robert K Jr)
26.07K
0.1%
-12.00K
-31.53%
Sep 27, 2024
查看更多
持股ETF
更新时间: 6月6日 周五
更新时间: 6月6日 周五
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
Dimensional US Core Equity 1 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
公告日期
类型
比率
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
